Titlebook: Cardiovascular Genetics for Clinicians; P. A. Doevendans,A. A. M. Wilde Book 2001 Springer Science+Business Media Dordrecht 2001 DNA.ather

相信

歡笑

Atrial Fibrillatione overall advance in the treatment of the cardiac dysrhythmias with the introduction of radio frequency ablation, therapeutic options in AF have remained largely unchanged and aimed at controlling the heart rate and anticoagulation. New surgical and ablation techniques are being developed, while pro

nitroglycerin

Genetics of Arrhythmogenic Right Ventricular Cardiomyopathye left ventricle [5– 8], less frequently to the interventricular septum [5]. Therefore, ARVD/C should no longer be regarded as cardiomyopathy confined to the right ventricle, as suggested by early observations. Patchy acute myocarditis patterns with myocyte death and focal round cell inflammatory in

eardrum

Genome Research and Future Healthcareerlying mutations have been identified. The first, highly valuable spin-off has been the development of specific and reliable diagnostics, thus relieving insecurity and long and burdening diagnostic odysseys. A welcome development first and foremost for patients and their relatives, but also for the

Exterior

多骨

1.8 Glossary of general abbreviations,ricle and occasionally right ventricular disease. DCM has an incidence of 4/100.00 per year. It is a leading cause for heart failure and an important indication for cardiac transplantation. The disease is associated with a high risk of sudden death due to ventricular arrhythmias and a high mortality rate of 15– 50% within 5 years.

floodgate

Outwit

neutralize

1.8 Glossary of general abbreviations, genetics have led to an increased of diagnostic, prognostic and in some cases even therapeutic possibilities. This progress has also entered cardiology. However, some physicians do not give sufficient information to patients prior to performing a genetic test and not aB other physicians have yet th

協(xié)迫